Filing an asbestos lawsuit allows victims of cancer and asbestos
exposure to hold accountable the companies who caused their diseases.
Asbestos, a mineral the World Health Organization has classified as a
human carcinogen, is the only known cause of mesothelioma. This mineral
was a popular choice of companies that wanted their products to be
durable and fire resistant throughout the twentieth century. However,
the health dangers of asbestos exposure were known by companies that
used asbestos as early as 1930s. Yet, they remained silent and used
asbestos anyway.
Hundreds of asbestos companies made the choice to poison hundreds of thousands of American workers, their families and consumers. As a result, it’s fair to say, anyone diagnosed with mesothelioma was exposed to asbestos and most often that exposure resulted from their job or a family member’s job.
Asbestos exposure may have happened when workers encountered products that contained asbestos. For example, auto mechanics could have installed asbestos brakes, drywallers may have used asbestos-containing joint compound, pipefitters could have encountered asbestos while cutting asbestos cement pipes, and it’s even possible for workers like managers who didn’t work directly with asbestos products, but were around others who did, to also be exposed. The list of asbestos products workers could have encountered goes on and on.
Learn more about asbestos exposure.
In the videos below, some of our clients and mesothelioma expert, Mary Hesdorffer, share their stories and provide reasons to file a mesothelioma claim.
- See more at:
http://www.weitzlux.com/firm-news/firm-news-2016/growing-number-of-invokana-lawsuits-in-pennsylvania-filed-by-wl/#sthash.08RCi2iN.dpuf
- See more at:
http://www.weitzlux.com/firm-news/firm-news-2016/growing-number-of-invokana-lawsuits-in-pennsylvania-filed-by-wl/#sthash.08RCi2iN.dpuf
Hundreds of asbestos companies made the choice to poison hundreds of thousands of American workers, their families and consumers. As a result, it’s fair to say, anyone diagnosed with mesothelioma was exposed to asbestos and most often that exposure resulted from their job or a family member’s job.
Asbestos exposure may have happened when workers encountered products that contained asbestos. For example, auto mechanics could have installed asbestos brakes, drywallers may have used asbestos-containing joint compound, pipefitters could have encountered asbestos while cutting asbestos cement pipes, and it’s even possible for workers like managers who didn’t work directly with asbestos products, but were around others who did, to also be exposed. The list of asbestos products workers could have encountered goes on and on.
Learn more about asbestos exposure.
“They (asbestos companies) didn’t care. They just thought, ‘Well, we’re going to make a lot of money now, and we’ll deal with the lawsuits later.'”
– Mary Jane, Peritoneal Mesothelioma Survivor, 13 years and counting
Why file a mesothelioma lawsuit?
In addition to holding the asbestos companies who harmed you accountable for their actions, filing a mesothelioma lawsuit can help you and your family cover medical expenses and lost wages. Mesothelioma is an expensive disease to treat; travel costs for visits to your mesothelioma specialist can add up quickly. Compensation from your mesothelioma lawsuit may allow you the flexibility to pay for any treatment costs that your insurance company will not cover. Simply put, filing a mesothelioma claim can allow you to take care of yourself during an exceedingly difficult time for you and your family.In the videos below, some of our clients and mesothelioma expert, Mary Hesdorffer, share their stories and provide reasons to file a mesothelioma claim.
Ellen
Relkin, of counsel attorney for Weitz and Luxenberg’s team focusing on
defective drugs and medical devices, has been filing lawsuits against
the manufacturers of Invokana. Those manufacturers are Janssen
Pharmaceuticals, and its affiliated companies Mitsubishi Tanabe
Pharmaceuticals and Johnson & Johnson. She spoke about the injuries
this drug is causing, including diabetic ketoacidosis, with The Legal
Intelligencer. Read more at Pa. Becoming Destination for Growing Invokana Litigation.
Cases filed by Weitz and Luxenberg also include those for serious
injuries involving urinary sepsis and kidney damage, as well as the
consequences of these problems, such as prolonged coma, sepsis and
necrotizing fasciitis.
Recent W&L Results
-
$1 BillionW&L's Ellen Relkin, as lead counsel in the NJ Rejuvenate and ABG II hip stem litigation, played a key role in negotiating the more than $1 billion settlement. Most qualifying plaintiffs will receive $300,000 or more.
-
$2.5 BillionW&L helped negotiate one of the largest mass tort settlements in recent history. More than 300 W&L clients are part of the settlement. Claimants had recalled DePuy ASR hips implanted and removed prior to August 31, 2013.
Ellen
Relkin, of counsel attorney for Weitz and Luxenberg’s team focusing on
defective drugs and medical devices, has been filing lawsuits against
the manufacturers of Invokana. Those manufacturers are Janssen
Pharmaceuticals, and its affiliated companies Mitsubishi Tanabe
Pharmaceuticals and Johnson & Johnson. She spoke about the injuries
this drug is causing, including diabetic ketoacidosis, with The Legal
Intelligencer. Read more at Pa. Becoming Destination for Growing Invokana Litigation.
Cases filed by Weitz and Luxenberg also include those for serious
injuries involving urinary sepsis and kidney damage, as well as the
consequences of these problems, such as prolonged coma, sepsis and
necrotizing fasciitis.
Recent W&L Results
-
$1 BillionW&L's Ellen Relkin, as lead counsel in the NJ Rejuvenate and ABG II hip stem litigation, played a key role in negotiating the more than $1 billion settlement. Most qualifying plaintiffs will receive $300,000 or more.
-
$2.5 BillionW&L helped negotiate one of the largest mass tort settlements in recent history. More than 300 W&L clients are part of the settlement. Claimants had recalled DePuy ASR hips implanted and removed prior to August 31, 2013.
No comments:
Post a Comment